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SUMMARY
Ordinary cuff-based blood pressure-monitoring devices remain a technical limitation that disturbs activities of daily life. Here we report a novel system for the cuff-less blood pressure estimation (CLB) that requires only 1 sensor for photoplethysmography. The present study is the first report to validate and assess the clinical application of the CLB in accordance with the latest wearable device standard (issued by Since the 1970s, oscillometric devices have become popular because they can be used to take multiple and automated measurements (5) . However, the oscillometric method still requires a cuff to compress the artery for BP measurement, which can disturb daily activities, particularly during ambulatory blood pressure monitoring (ABPM) (6) .
The most recent guidelines for the care of hypertension have emphasized home BP monitoring and ABPM (7, 8) . However, an ordinary CB allows only a "snapshot" or intermittent assessment of BP, and the inflation of a cuff can induce discomfort, especially during ABPM, which often affects the BP data (6, 9) and disturbs examinees' daily activities (6) .
Many technical innovations have been developed for
BP monitoring, such as BP estimation sensors, mobile apps, and wearable devices (10) . Among these, a BP sensor measuring pulse transit time (i.e., the time interval from left ventricular contraction to pulse waveform acquisition at the extremity) is one of the most promising candidates (11) . However, no system has been developed to enable BP estimation and continuous monitoring by a single sensor that has comparable fidelity to the CB (12) .
The goal of the present study was to develop a new device for recording BP without a cuff. We report a novel system for cuff-less blood pressure Watanabe et al. In brief, this guideline describes the fidelity requirements that are determined by the mean absolute difference (MAD) of BP between values estimated by using a test device (i.e., CLB) and those measured by using an ordinary CB under 3 different
conditions. An overview of the study protocol is displayed in Figure 1B After the calibration, 3 pairs of BP measurements were taken for each subject using both CLB and CB simultaneously, as described in the previous section.
SCORING OF THE IMPACT OF ABPM ON SLEEP
QUALITY. Thirty-five participants were subjected to bedtime BP monitoring by either CB (i.e., ABPM) (Study 1) or CLB (Study 2) on 2 separate calendar days.
Between Study 1 and Study 2, 2-month intervals were set to avoid any interference that might occur by wearing order, such as the lack of sleep in a previous night induced by CB. Immediately after the device was detached, each examinee completed the sleep quality questionnaire. A questionnaire about sleep quality was used to screen for discomfort during BP monitoring by standard ABPM or CLB.
Sleep quality was rated on a scale using 0, 1, and 2.
Fair sleep quality during BP monitoring was rated as 2; mildly disturbed sleep was rated as 1; and if sleep quality deteriorated or the subject was unable to sleep, a score of 0 was recorded.
To address the impact of BP-monitoring device on sleep disturbance in a more objective fashion, electrocardiogram (ECG) data were simultaneously Values are mean AE SD, n (%), or mean AE SD [MAD †]. *Participant who has been diagnosed and treated with antihypertensive medication. †Mean absolute difference (MAD) between the blood pressure (BP) value of the test device (CLB) and the reference device (CB), the cuff-wearing sphygmomanometer. According to the Institute of Electrical and Electronics Engineers standard, the accuracy of the cuff-less BP devise was assessed by the sufficient number of systolic blood pressure (SBP) rise and decline in the range of 0 to 30 mm Hg. The accuracy limit of BP estimation was determined by the MAD of BP (<7 mm Hg difference between the CLB and the reference device. DBP ¼ diastolic blood pressure; PR ¼ pulse rate recorded by CLB. Calibration was performed at the beginning of each measurement using a cuff-type sphygmomanometer to take 3 measurements at 60-s intervals. After calibration, simultaneous BP monitoring was performed by using CLB and CB under (C) static conditions followed by dynamic measurements using (E) leg stretching and a clamp. ADC ¼ analog to digital converter; Amp ¼ amplifier; PC ¼ personal computer.
Watanabe et al.
A New Device for Blood Pressure Estimation were calculated ( Table 2) . In general, an ICC >0.8
represents good repeatability of measurements, and an ICC >0.9 represents excellent repeatability. To assess the reproducibility of the measurements, the ICC and its 95% CIs were calculated ( Table 2) . Table 1 for baseline characteristics of participants [n ¼ 29]). As expected, the intracoronary administration of nitroglycerin (1.5 mg) (protocol is displayed in Figure 3A) induced a decrease in BP of approximately 30 mm Hg The reproducibility of the measurements, the ICC and its 95% confidence interval (CI) value between the BP value of test device (CLB) and the reference device (CB; cuff-wearing sphygmomanometer), were calculated. In general, an ICC >0.8 represents good repeatability, and an ICC >0.9 represents excellent repeatability of measurements.
ICC ¼ intraclass correlation coefficient; other abbreviations as in Table 1 .
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A New Device for Blood Pressure Estimation ( Figures 3B and 3C ). Despite the rapid response occurring over a few minutes, the CLB measurements were highly correlated with the changes in BP (R ¼ 0.86, p < 0.001 for SBP [ Figure 3D] To address whether CLB sensitivity may be altered in response to these dynamic BP changes, the BP distribution patterns measured by CB and CLB were compared by using a histogram. In SBP, the BP distribution pattern appeared identical to that measured by CB under independent recording conditions (Supplemental Figures 4A to 4C ). In contrast, the histogram of DBP from CLB was not identical to that measured by CB under dynamic conditions (i.e., rising and falling BP).
EFFECTS OF THE CLB AND ORDINARY ABPM ON
SLEEP QUALITY. One of the expected advantages of the CLB is its use in the continuous recording of BP variability (6) . We therefore conducted a pilot study to compare the CLB and cuff-type ABPM during sleep.
Thirty-five participants (Supplemental Table 1 ) were subjected to BP monitoring during sleep using an ordinary automated CB (i.e., ABPM; Study 1). The next morning, they scored their discomfort and sleep quality using a simple questionnaire (details noted in the Methods section). A second study using CLB was performed on a separate calendar day, after an interval of >2 months ( Figure 4A ). There were no differences in the mean SBP or DBP measurements between the 2 devices (Supplemental Figure 5A) . The questionnaire revealed that >70% of participants felt uncomfortable when wearing an ordinary cuff-type ABPM ( Figure 4B ), and this rate was significantly reduced when wearing a CLB, suggesting that sleep quality was significantly preserved during overnight BP monitoring with a CLB.
To address the objective impact of CLB on sleep quality, we measured HR variability ( Figures 4C to 4E) by using the ECG data simultaneously obtained from the CLB device. These variables were measured in terms of the changes in HR, the HF component of HR variability, and the ratio of the LF component of HR variability and HF (i.e., LF/HF). Notably, HR, HF, and LF/HF were significantly lower in the CLB group exclusively in the first hour after going to bed (i.e., the time to onset of sleep). In contrast, there were no significant differences in HR or the LF/HF ratio during the total duration of sleep (8 h) (Supplemental Figures 5B and 5C ). In the present study, on the basis of innovative sensor assemblies and an algorithm, CLB demonstrated high precision and agreement with standard CB through the validation of BP measurements under static and dynamic conditions (Figures 1 to 3 ).
We further certified that the CLB met the validation and reproducibility criteria through follow-up measurements ( Figures 2E and 2F ).
FIGURE 4 Continued
The effect of BP measurement during sleep was evaluated in terms of discomfort using (B) a questionnaire about sleep quality and (C to F) physiological parameters (heart rate [HR], high-frequency [HF] , and low-frequency [LF]/HF). (A) Examinees were randomly assigned and subjected to a bedtime BP monitoring study using standard ambulatory BP monitoring (ABPM) (Study 1). More than 2 months later, the same examinees were subjected to bedtime BP monitoring using the CLB (Study 2). To avoid any bias resulting from device order, the second study was performed after a long interval. There were no significant differences in the mean SBP or DBP recorded by using either of these devices (Supplemental Figure 5A) . which is more sensitive to the case of peripheral measurement of DBP than to the measurement of SBP by pulse transit time (25, 26) . This alteration is believed to result from changes in the correlation between pulse transit time (i.e., pulse wave velocity) and arterial wall distensibility in response to exercise (26, 27 (11, 12, 33) .
One such limitation is calibration. To convert the PTG signal into BP, calibration using CB is unavoidable.
We are not yet free from the cuff, and our device is therefore termed "cuff-less," not "cuff-free." However, our CLB has the advantage of using a single sensor for BP recording, unlike previous devices that require multiple sensors (15) . For cuff-less BP monitoring to be user-friendly (11) , the use of multiple sensors should not limit portability or flexibility.
Gesche et al. (33) showed that BP estimation using PTG and ECG is regarded as more convenient and less costly because this method requires only an estimation algorithm, ECG, and a finger PTG sensor (33) .
More recently, a Taiwanese company has developed a cuff-less BP reading device that is already commercially available (34) . Notably, compared with our device that requires only a PTG signal for BP estimation, 
CONCLUSIONS
We have developed a novel BP-monitoring sensor using innovative digital technology. Although our
device has yet to overcome the requirement for pre-calibration using CB, our study shows the high precision and great advantage of CLB as a paradigm shift in BP monitoring in the digital health era.
